Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant glioma
Open Access
- 21 March 2017
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (23) , 37511-37524
Abstract
Promoting oligodendroglial-oriented differentiation of glioma stem cell: a repurposing of quetiapine for the treatment of malignant gliomaKeywords
This publication has 47 references indexed in Scilit:
- Wnt inhibition is dysregulated in gliomas and its re-establishment inhibits proliferation and tumor sphere formationExperimental Cell Research, 2016
- Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistanceNature Communications, 2015
- Increased Notch Signaling Enhances Radioresistance of Malignant Stromal Cells Induced by Glioma Stem/ Progenitor CellsPLOS ONE, 2015
- Quetiapine inhibits osteoclastogenesis and prevents human breast cancer-induced bone loss through suppression of the RANKL-mediated MAPK and NF-κB signaling pathwaysBreast Cancer Research and Treatment, 2015
- Effect of Notch expression in glioma stem cells on therapeutic response to chemo-radiotherapy in recurrent glioblastomaBrain Tumor Pathology, 2015
- Chemotherapy for adults with malignant glioma: a systematic review and network meta-analysisTurkish Neurosurgery, 2015
- Differentiation Therapy Exerts Antitumor Effects on Stem-like Glioma CellsClinical Cancer Research, 2010
- A Hierarchy of Self-Renewing Tumor-Initiating Cell Types in GlioblastomaCancer Cell, 2010
- Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma MultiformeClinical Cancer Research, 2008
- Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changesMolecular Psychiatry, 2007